ERNA vs NKE · P/E 0.0, rev $582.0K vs P/E 35, rev $46.31B
Eterna Therapeutics Inc (ERNA) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the ERNA and NKE stock pages for the full models.
Not investment advice.